In reply: Our case series1 aimed to alert health practitioners to the types of hospital presentations associated with naltrexone implants and issues in managing such patients, particularly as these have not been well documented in the medical literature. These letters appear critical of any such communication.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
